WallStreetZenWallStreetZen

NYSEMKT: MNK
Mallinckrodt PLC Stock

Open Broker Account
$9.69-0.18 (-1.82%)
Updated Dec 9, 2022
MNK Price
$9.69
Fair Value Price
N/A
Market Cap
$127.63M
52 Week Low
$8.96
52 Week High
$18.10
P/E
N/A
P/B
0.07x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
2.38
Operating Cash Flow
N/A
Beta
-0.19
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

Zen Score

Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how MNK scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

MNK is good value based on its book value relative to its share price (0.07x), compared to the US Drug Manufacturers - Specialty & Generic industry average (1.75x)
P/B vs Industry Valuation
MNK's short-term assets ($2.17B) exceed its short-term liabilities ($779.10M)
Short-term Liabilities Financials
MNK's long-term liabilities ($3.63B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
There are 30 more MNK due diligence checks available for Premium users.

Be the first to know about important MNK news, forecast changes, insider trades & much more!

MNK News

Valuation

MNK price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.07x
Industry
1.75x
MNK is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

MNK's financial health

Profit margin

Revenue
$550.4M
Net Income
-$348.6M
Profit Margin
-63.3%

Assets to liabilities

Assets
$6.3B
Liabilities
$4.4B
Debt to equity
2.38
MNK's short-term assets ($2.17B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MNK's long-term liabilities ($3.63B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MNK's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$19.3M
Investing
$49.6M
Financing
-$17.3M

MNK vs Pharmaceutical Stocks

TickerMarket Cap1d %P/EP/B
MNK$127.63M-1.82%N/A0.07x
TKNO$127.99M-0.66%-3.45x1.14x
OPTN$145.33M-7.94%-1.89x-1.98x
THTX$99.90M-8.70%-2.84x-7.63x
HEXO$97.96M+1.24%-0.08x0.43x

Mallinckrodt Stock FAQ

What is Mallinckrodt's quote symbol?

NYSEMKT: MNK) Mallinckrodt trades on the NYSEMKT under the ticker symbol MNK. Mallinckrodt stock quotes can also be displayed as NYSEMKT: MNK.

If you're new to stock investing, here's how to buy Mallinckrodt stock.

What is the 52 week high and low for Mallinckrodt (NYSEMKT: MNK)?

(NYSEMKT: MNK) Mallinckrodt's 52-week high was $18.10, and its 52-week low was $8.96. It is currently -46.46% from its 52-week high and 8.15% from its 52-week low.

How much is Mallinckrodt's stock price per share?

(NYSEMKT: MNK) Mallinckrodt stock price per share is $9.69 today (as of Dec 9, 2022).

What is Mallinckrodt's Market Cap?

(NYSEMKT: MNK) Mallinckrodt's market cap is $127.63M, as of Dec 10, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Mallinckrodt's market cap is calculated by multiplying MNK's current stock price of $9.69 by MNK's total outstanding shares of 13,170,932.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.